Other prognostic factors with significant HRs for death were short time on ADT, lymph node metastases, low Hb, high PSA and high ALP, poor ECOG performance status, and systemic treatment in addition to ADT prior to CRPC. Here, GSTM1 is linked to metastatic malignant neoplasm in the lymph nodes.